Home Medicine Fetal hematological phenotypes of various hemoglobinopathies and demonstration of embryonic hemoglobins on capillary electrophoresis: a large cohort data from prenatal screening program
Article
Licensed
Unlicensed Requires Authentication

Fetal hematological phenotypes of various hemoglobinopathies and demonstration of embryonic hemoglobins on capillary electrophoresis: a large cohort data from prenatal screening program

  • Kritsada Singha , Supawadee Yamsri , Attawut Chaibunruang , Hataichanok Srivorakun , Anupong Pansuwan , Kanokwan Sanchaisuriya , Goonnapa Fucharoen and Supan Fucharoen EMAIL logo
Published/Copyright: January 30, 2025

Abstract

Objectives

This study reported a large cohort of fetal blood analysis of various hemoglobinopathies.

Methods

A total of 371 fetal blood specimens were recruited. Complete blood count and hemoglobin (Hb) analysis using capillary electrophoresis were performed. Genotypes were defined by DNA analysis.

Results

Among 371 fetuses, 36 were non-thalassemic and 29 thalassemia genotypes were identified in the remaining 335 fetuses. Fetuses with β-thalassemia and Hb E traits, homozygous Hb E, and Hb E-β0-thalassemia had similar hematological parameters as those of non-thalassemic. However, the levels of Hb A in β-thalassemia and Hb E traits were approximately half of that observed in the non-thalassemic fetuses. As for Hb E, fetuses with a single copy of the βE-globin gene in the Hb E trait and Hb E-β0-thalassemia had lower Hb E levels as compared to that of the homozygous Hb E. For α-thalassemia, fetuses with one or two α-globin gene defects had small changes in hematological parameters, but variable Hb Bart’s levels were observed. Fetuses with Hb H and Hb H-CS diseases had moderate anemia, whereas those with homozygous Hb CS and Hb Bart’s hydrops fetalis had severe anemia. Identification of the fetuses with Hb Bart’s hydrops fetalis with various genetic interactions allows the exact re-location of electrophoretic mobilities of various embryonic Hbs.

Conclusions

This study confirmed the genetic heterogeneity of hemoglobinopathies among the fetuses and fetal blood analysis are useful for presumptive diagnosis of hemoglobinopathies. The results should facilitate a prevention and control program of hemoglobinopathies in the region.


Corresponding author: Dr. Supan Fucharoen, Faculty of Associated Medical Sciences, Centre for Research and Development of Medical Diagnostic Laboratories, Khon Kaen University, Khon Kaen, 40002, Thailand, E-mail:

Funding source: Mahasarakham University

Award Identifier / Grant number: not available

Funding source: Khon Kaen University

Award Identifier / Grant number: RP67-2 Research Center KKU-001

Acknowledgments

We thank Drs. Thawalwong Ratanasiri, Ratana Komwilaisakde, and Piyamas Saksiriwuttho of the Department of Obstetrics and Gynecology, Faculty of Medicine, Khon Kaen University for help in fetal specimen collection.

  1. Research ethics: The study protocol received ethical approval from the Institutional Review Board (IRB) of Khon Kaen University, Thailand (HE652154).

  2. Informed consent: Informed consent was obtained from all individuals included in this study.

  3. Author contributions: KrS designed the study, performed experiments, analyzed the data, and developed the initial manuscript. SY, AC, HS, and AP helped in laboratory investigation and clinical data acquisition. KS and GF performed data analysis and interpretation of the cases. SF supervised results interpretation, designed and facilitated the study, acquired a research grant, and critically revised and approved the final manuscript. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interest: The authors state no conflict of interest.

  6. Research funding: This project was financially supported by Khon Kaen University, Thailand, to SF (Contract ID: RP67-2-Research Center KKU-001) and Mahasarakham University, Thailand, to KrS.

  7. Data availability: Further inquiries or data in this study can be directed to the corresponding author.

References

1. Fucharoen, S, Weatherall, DJ. Progress toward the control and management of the thalassemias. Hematol Oncol Clin N Am 2016;30:359–71. https://doi.org/10.1016/j.hoc.2015.12.001.Search in Google Scholar PubMed

2. Yamsri, S, Sanchaisuriya, K, Fucharoen, G, Sae-Ung, N, Ratanasiri, T, Fucharoen, S. Prevention of severe thalassemia in northeast Thailand: 16 years of experience at a single university center. Prenat Diagn 2010;30:540–6. https://doi.org/10.1002/pd.2514.Search in Google Scholar PubMed

3. Fucharoen, G, Sanchaisuriya, K, Sae-ung, N, Dangwibul, S, Fucharoen, S. A simplified screening strategy for thalassaemia and haemoglobin E in rural communities of Southeast Asia. Bull World Health Organ 2004;82:364–72.Search in Google Scholar

4. Sanchaisuriya, K, Fucharoen, S, Fucharoen, G, Ratanasiri, T, Sanchaisuriya, P, Changtrakul, Y, et al.. A reliable screening protocol for thalassemia and hemoglobinopathies in pregnancy; an alternative approach to electronic blood cell counting. Am J Clin Pathol 2005;123:113–8. https://doi.org/10.1309/fuf9evgq24v1pktp.Search in Google Scholar PubMed

5. Fucharoen, S, Winichagoon, P, Thonglairoam, V, Siriboon, W, Siritanaratkul, N, Kanokpongsakdi, S, et al.. Prenatal diagnosis of thalassemia and hemoglobinopathies in Thailand: experience from 100 pregnancies. Southeast Asian J Trop Med Publ Health 1991;22:16–29.Search in Google Scholar

6. Kazazian, HHJr. The thalassemia syndromes: molecular basis and prenatal diagnosis in 1990. Semin Hematol 1990;27:209–28.Search in Google Scholar

7. Forestier, F, Daffos, F, Galactéros, F, Bardakjian, J, Rainaut, M, Beuzard, Y. Hematological values of 163 normal fetuses between 18 and 30 weeks of gestation. Pediatr Res 1986;20:342–6. https://doi.org/10.1203/00006450-198604000-00017.Search in Google Scholar PubMed

8. Forestier, F, Daffos, F, Catherine, N, Renard, M, Andreux, JP. Developmental hematopoiesis in normal human fetal blood. Blood 1991;77:2360–3. https://doi.org/10.1182/blood.v77.11.2360.bloodjournal77112360.Search in Google Scholar

9. Srisupundit, K, Piyamongkol, W, Tongsong, T. Comparison of red blood cell hematology among normal, alpha-thalassemia-1 trait, and hemoglobin Bart’s fetuses at mid-pregnancy. Am J Hematol 2008;83:908–10. https://doi.org/10.1002/ajh.21287.Search in Google Scholar PubMed

10. Srivorakun, H, Fucharoen, G, Sae-Ung, N, Sanchaisuriya, K, Ratanasiri, T, Fucharoen, S. Analysis of fetal blood using capillary electrophoresis system: a simple method for prenatal diagnosis of severe thalassemia diseases. Eur J Haematol 2009;83:57–65. https://doi.org/10.1111/j.1600-0609.2009.01245.x.Search in Google Scholar PubMed

11. Li, TK, Leung, KY, Lam, YH, Tang, MH, Chan, V. Haemoglobin level, proportion of haemoglobin Bart’s and haemoglobin Portland in fetuses affected by homozygous α0-thalassemia from 12 to 40 weeks’ gestation. Prenat Diagn 2010;30:1126–30. https://doi.org/10.1002/pd.2619.Search in Google Scholar PubMed

12. Srisupundit, K, Wanapirak, C, Sirichotiyakul, S, Tongprasert, F, Luewan, S, Traisrisilp, K, et al.. Fetal red blood cell hematology at mid-pregnancy among fetuses at risk of homozygous β-thalassemia disease. J Pediatr Hematol Oncol 2013;35:628–30. https://doi.org/10.1097/mph.0b013e3182a2717a.Search in Google Scholar

13. Srisupundit, K, Wanapirak, C, Sirichotiyakul, S, Tongprasert, F, Leuwan, S, Traisrisilp, K, et al.. Hemoglobin levels and red blood cell indices in mid-gestational fetuses with beta-thalassemia/HbE, beta-thalassemia trait or Hb E trait and normal fetuses. Prenat Diagn 2013;33:1238–41. https://doi.org/10.1002/pd.4237.Search in Google Scholar PubMed

14. Karnpean, R, Fucharoen, G, Fucharoen, S, Ratanasiri, T. Fetal red blood cell parameters in thalassemia and hemoglobinopathies. Fetal Diagn Ther 2013;34:166–71. https://doi.org/10.1159/000354343.Search in Google Scholar PubMed

15. Zhan, W, Guo, H, Hu, S, Wang, J, Qin, D, Liang, J, et al.. Comparison of cord blood hematological parameters among normal, α-thalassemia, and β-thalassemia fetuses between 17 and 38 weeks of gestation. Sci Rep 2021;11:3844. https://doi.org/10.1038/s41598-021-82297-y.Search in Google Scholar PubMed PubMed Central

16. Charoenwijitkul, T, Singha, K, Fucharoen, G, Sanchaisuriya, K, Thepphitak, P, Wintachai, P, et al.. Molecular characteristics of α+-thalassemia (3.7 kb deletion) in Southeast Asia: molecular subtypes, haplotypic heterogeneity, multiple founder effects and laboratory diagnostics. Clin Biochem 2019;71:31–7. https://doi.org/10.1016/j.clinbiochem.2019.06.005.Search in Google Scholar PubMed

17. Chaibunruang, A, Karnpean, R, Fucharoen, G, Fucharoen, S. Genetic heterogeneity of hemoglobin AEBart’s disease: a large cohort data from a single referral center in northeast Thailand. Blood Cells Mol Dis 2014;52:176–80. https://doi.org/10.1016/j.bcmd.2013.11.006.Search in Google Scholar PubMed

18. Weatherall, DJ, Clegg, JB. The thalassemia syndromes, 4th ed. Oxford, UK: Blackwell; 2001.10.1002/9780470696705Search in Google Scholar

19. Steinberg, MH, Forget, BG, Higgs, DR, Weatherall, DJ. Disorders of hemoglobin: genetics, pathophysiology, and clinical management, 2nd ed. Cambridge, UK: Cambridge University Press; 2009.10.1017/CBO9780511596582Search in Google Scholar

20. Hoffman, R, Benz, EJ, Silberstein, LE, Heslop, HE, Weitz, JI, Anastasi, J, et al.. Hematology, basic principles, and practice, 7th ed. Philadelphia: Elsevier; 2018.Search in Google Scholar

21. Charoenkwan, P, Sirichotiyakul, S, Chanprapaph, P, Tongprasert, F, Taweephol, R, Sae-Tung, R, et al.. Anemia and hydrops in a fetus with homozygous hemoglobin constant spring. J Pediatr Hematol Oncol 2006;28:827–30. https://doi.org/10.1097/01.mph.0000243662.56432.37.Search in Google Scholar PubMed

22. He, S, Zheng, C, Meng, D, Chen, R, Zhang, Q, Tian, X, et al.. Hb H hydrops fetalis syndrome caused by association of the - -(SEA) deletion and Hb constant spring (HBA2: c.427T > C) mutation in a Chinese family. Hemoglobin 2015;39:216–9. https://doi.org/10.3109/03630269.2015.1030031.Search in Google Scholar PubMed

23. Komvilaisak, P, Komvilaisak, R, Jetsrisuparb, A, Wiangnon, S, Jirapradittha, J, Kiatchoosakun, P, et al.. Fetal anemia causing hydrops fetalis from an alpha-globin variant: homozygous hemoglobin constant spring. J Pediatr Hematol Oncol 2018;40:405–8. https://doi.org/10.1097/mph.0000000000001051.Search in Google Scholar PubMed

24. Sirilert, S, Charoenkwan, P, Sirichotiyakul, S, Tongprasert, F, Srisupundit, K, Luewan, S, et al.. Prenatal diagnosis and management of homozygous hemoglobin Constant Spring disease. J Perinatol 2019;39:927–33. https://doi.org/10.1038/s41372-019-0397-7.Search in Google Scholar PubMed

25. Singha, K, Yamsri, S, Chaibunruang, A, Srivorakun, H, Sanchaisuriya, K, Fucharoen, G, et al.. Diagnostic value of fetal hemoglobin Bart’s for evaluation of fetal α-thalassemia syndromes: application to prenatal characterization of fetal anemia caused by undiagnosed α-hemoglobinopathy. Orphanet J Rare Dis 2022;17:45. https://doi.org/10.1186/s13023-022-02197-w.Search in Google Scholar PubMed PubMed Central

26. Randhawa, ZI, Jones, RT, Lie-Injo, LE. Human hemoglobin Portland II (zeta 2 beta 2). Isolation and characterization of Portland hemoglobin components and their constituent globin chains. J Biol Chem 1984;259:7325–30. https://doi.org/10.1016/s0021-9258(17)39875-7.Search in Google Scholar

27. Li, Y, Liang, L, Tian, M, Qing, T, Wu, X. Electrophoresis features and genotypes of Hb Bart’s hydrops fetalis. Scand J Clin Lab Invest 2020;80:129–32. https://doi.org/10.1080/00365513.2019.1703211.Search in Google Scholar PubMed

28. Shevtsov, A, Parada, M, Burks, EJ, Quillen, K. Peripheral blood smear and hemoglobin electrophoresis of unsuspected hemoglobin Bart’s hydrops fetalis in a newborn. Int J Lab Hematol 2022;44:53–4. https://doi.org/10.1111/ijlh.13677.Search in Google Scholar PubMed


Supplementary Material

This article contains supplementary material (https://doi.org/10.1515/dx-2024-0190).


Received: 2024-11-30
Accepted: 2025-01-07
Published Online: 2025-01-30

© 2025 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Reviews
  3. Accuracy of pulse wave velocity for screening coronary artery disease: a systematic review and meta-analysis
  4. Prenatal screening for genetic disorders: updated guidelines, proposed counseling, a holistic approach for primary health care providers in developing countries
  5. A scoping review of fever of unknown origin with normal serum C-reactive protein
  6. Mini Review
  7. Overview of dengue diagnostic limitations and potential strategies for improvement
  8. Opinion Papers
  9. Demystifying cognitive bias in the diagnostic process for frontline clinicians and educators; new words for old ideas
  10. Physicians’ prism: illuminating history with structured expertise
  11. Original Articles
  12. Implementation of a curriculum on communicating diagnostic uncertainty for clerkship-level medical students: a pseudorandomized and controlled study
  13. A synthesized differential diagnosis is associated with fewer diagnostic errors compared to an inventorial list
  14. Equity-Driven Diagnostic Excellence framework: An upstream approach to minimize risk of diagnostic inequity
  15. Two decades of autopsy-detected diagnostic errors in Japan
  16. Does management reasoning display context specificity? An exploration of sleep loss and other distracting situational (contextual) factors in clinical reasoning
  17. Cognitive biases in osteopathic diagnosis: a mixed study among French osteopaths
  18. Racial and ethnic disparities in pediatric emergency department patients with missed opportunities for diagnostic excellence
  19. Diagnostic accuracy of non-mydriatic fundus photography as a triage and telemedicine tool for patients with vision loss
  20. “Innumerable” lesion burden on brain MRI ‒ a diagnostic approach
  21. Factors associated with positive findings of deep infection on computed tomography among patients with extremity cellulitis
  22. Exploring emergency department providers’ uncertainty in neurological clinical reasoning
  23. Analytical performance and user-friendliness of four point-of-care measuring systems for monitoring prothrombin time international normalized ratio in the hands of the intended users
  24. Fetal hematological phenotypes of various hemoglobinopathies and demonstration of embryonic hemoglobins on capillary electrophoresis: a large cohort data from prenatal screening program
  25. Development and assessment of autoverification system for routine coagulation assays in inpatient and outpatient settings of tertiary care hospital: algorithm performance and impact on laboratory efficiency
  26. Validation of new, circulating biomarkers for gliomas
  27. Short Communications
  28. Using language to evaluate curricular impact: a novel approach in assessing clinical reasoning curricula
  29. Comparative evaluation of routine coagulation testing on Stago sthemO 301 and Werfen ACL TOP 750
  30. Letters to the Editor
  31. Reversible systemic vasoconstriction syndrome: a new diagnostic family of generalized vasospasm in multiple organs
  32. The value of designating symptoms as “vague” in diagnosis
  33. Immunoglobulin E in an inverted skin-prick test for rapid detection of cutaneous antigens
Downloaded on 19.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/dx-2024-0190/html
Scroll to top button